External validation of blood eosinophils, FENO and serum periostin as surrogates for sputum eosinophils in asthma

…, SB de Nijs, R Lutter, AR Sousa, EJM Weersink… - Thorax, 2015 - thorax.bmj.com
Background Monitoring sputum eosinophils in asthma predicts exacerbations and improves
management of asthma. Thus far, blood eosinophils and FE NO show contradictory results …

Synbiotics reduce allergen‐induced T‐helper 2 response and improve peak expiratory flow in allergic asthmatics

MA Van De Pol, R Lutter, BS Smids, EJM Weersink… - Allergy, 2011 - Wiley Online Library
To cite this article: van de Pol MA, Lutter R, Smids BS, Weersink EJM, van der Zee JS.
Synbiotics reduce allergen‐induced T‐helper 2 response and improve peak expiratory flow in …

Three phenotypes of adult‐onset asthma

…, R Lutter, AH Zwinderman, EJM Weersink… - Allergy, 2013 - Wiley Online Library
Rationale Adult‐onset asthma differs from childhood‐onset asthma in many respects. It is
more heterogeneous, often severe and frequently associated with loss of lung function. To …

Bronchial thermoplasty induced airway smooth muscle reduction and clinical response in severe asthma. The TASMA randomized trial

…, NHT Ten Hacken, EJM Weersink… - American journal of …, 2021 - atsjournals.org
Rationale: Bronchial thermoplasty (BT) is a bronchoscopic treatment for severe asthma
targeting airway smooth muscle (ASM). Observational studies have shown ASM mass reduction …

[HTML][HTML] Health-related quality of life in end-stage COPD and lung cancer patients

…, JM Gore, MA Greenstone, EJM Weersink… - Journal of pain and …, 2009 - Elsevier
Historically, palliative care has been developed for cancer patients and is not yet generally
available for patients suffering from chronic life-limiting illnesses, such as chronic obstructive …

[HTML][HTML] Poor outcome of SARS-CoV-2 infection in patients with severe asthma on biologic therapy

…, KW Patberg, A Beukert, F Smeenk, EJM Weersink… - Respiratory …, 2021 - Elsevier
Background It is unclear whether asthma and asthma medications increase or decrease the
risk of severe COVID-19, and this is particularly true for patients with severe asthma …

[HTML][HTML] Complications of switching from anti–IL-5 or anti–IL-5R to dupilumab in corticosteroid-dependent severe asthma

K Eger, L Pet, EJM Weersink… - The Journal of Allergy and …, 2021 - jaci-inpractice.org
In rare cases, antieIL-4/13 for severe asthma can cause hypereosinophilia, with sudden
deterioration of asthma, eosinophilic tissue infiltration, and eosinophilic granulomatosis with …

Alpine altitude climate treatment for severe and uncontrolled asthma: An EAACI position paper

…, DG Peroni, G Piacentini, EJM Weersink… - Allergy, 2022 - Wiley Online Library
Currently available European Alpine Altitude Climate Treatment (AACT) programs combine
the physical characteristics of altitude with the avoidance of environmental triggers in the …

Characteristics and treatment regimens across ERS SHARP severe asthma registries

…, JK Sont, SJH Vijverberg, EJM Weersink… - European …, 2020 - Eur Respiratory Soc
Little is known about the characteristics and treatments of patients with severe asthma
across Europe, but both are likely to vary. This is the first study in the European Respiratory …

Health-related quality of life and functional status in end-stage COPD: a longitudinal study

…, G ter Riet, EJM Weersink… - European …, 2011 - Eur Respiratory Soc
Since there is still a dearth of information about the end stage of chronic obstructive pulmonary
disease (COPD), the main aim of this study was to examine the development of health-…